Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: The influence of pituitary magnetic resonance imaging findings

被引:57
作者
Coutant, R
Rouleau, S
Despert, F
Magontier, N
Loisel, D
Limal, JMA
机构
[1] Univ Hosp, Dept Pediat, F-49000 Angers, France
[2] Univ Hosp, Dept Radiol, F-49000 Angers, France
[3] Univ Hosp, Dept Pediat, F-37000 Tours, France
关键词
D O I
10.1210/jc.86.10.4649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We analyzed the final height of 146 short children with either nonacquired GH deficiency or idiopathic short stature. Our purpose was 1) to assess growth according to the pituitary magnetic resonance imaging findings in the 63 GH-treated children with GH deficiency and 2) to compare the growth of the GH-deficient patients with normal magnetic resonance imaging (n = 48) to that of 32 treated and 51 untreated children with idiopathic short stature (GH peak to provocative tests >10 mug/liter). The mean GH dose was 0.44 IU/kg.wk (0.15 mg/kg-wk), given for a mean duration of 4.6 yr. Among the GH-deficient children, 15 had hypothalamic-pituitary abnormalities (stalk agenesis), all with total GH deficiency (GH peak <5 <mu>g/liter). They were significantly shorter and younger at the time of diagnosis than those with normal magnetic resonance imaging, had better catch-up growth (+2.7 +/- 0.9 vs. +1.3 +/- 0.8 SD score; P < 0.01), and reached greater final height (-1.1 +/- 1.0 vs. -1.7 +/- 1.0 SD score; P < 0.05). Among patients with normal magnetic resonance imaging, there was no difference in catch-up growth and final height between partial and total GH deficiencies. GH-deficient subjects with normal magnetic resonance imaging and treated and untreated patients with idiopathic short stature had comparable auxological characteristics, age at evaluation, and target height. Although they had different catch-up growth (+1.3 +/- 0.8, +0.9 +/- 0.6, and +0.7 +/- 0.9 SD score, respectively; P < 0.01, by ANOVA), these patients reached a similar final height (-1.7 +/- 1.0, -2.1 +/- 0.8, and -2.1 +/- 1.0 SD score, respectively; P = 0.13). Pituitary magnetic resonance imaging findings show the heterogeneity within the group of nonacquired GH deficiency and help to predict the response to GH treatment in these patients. The similarities in growth between the GH-deficient children with normal magnetic resonance imaging and those with idiopathic short stature suggest that the short stature in the former subjects is at least partly due to factors other than GH deficiency.
引用
收藏
页码:4649 / 4654
页数:6
相关论文
共 41 条
  • [1] MAGNETIC-RESONANCE-IMAGING IN THE DIAGNOSIS OF GROWTH-HORMONE DEFICIENCY
    ARGYROPOULOU, M
    PERIGNON, F
    BRAUNER, R
    BRUNELLE, F
    [J]. JOURNAL OF PEDIATRICS, 1992, 120 (06) : 886 - 891
  • [2] TABLES FOR PREDICTING ADULT HEIGHT FROM SKELETAL AGE - REVISED FOR USE WITH THE GREULICH-PYLE HAND STANDARDS
    BAYLEY, N
    PINNEAU, SR
    [J]. JOURNAL OF PEDIATRICS, 1952, 40 (04) : 423 - 441
  • [3] FACTORS PREDICTING THE RESPONSE TO GROWTH-HORMONE (GH) THERAPY IN PREPUBERTAL CHILDREN WITH GH DEFICIENCY
    BLETHEN, SL
    COMPTON, P
    LIPPE, BM
    ROSENFELD, RG
    AUGUST, GP
    JOHANSON, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (03) : 574 - 579
  • [4] Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH
    Blethen, SL
    Baptista, J
    Kuntze, J
    Foley, T
    LaFranchi, S
    Johanson, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) : 418 - 420
  • [5] A SPECIFIC RADIOIMMUNOASSAY FOR THE GROWTH-HORMONE (GH)-DEPENDENT SOMATOMEDIN-BINDING PROTEIN - ITS USE FOR DIAGNOSIS OF GH DEFICIENCY
    BLUM, WF
    RANKE, MB
    KIETZMANN, K
    GAUGGEL, E
    ZEISEL, HJ
    BIERICH, JR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (05) : 1292 - 1298
  • [6] FINAL HEIGHT IN CHILDREN WITH GROWTH-HORMONE DEFICIENCY
    BRAMSWIG, J
    SCHLOSSER, H
    KIESE, K
    [J]. HORMONE RESEARCH, 1995, 43 (04) : 126 - 128
  • [7] BURNS EC, 1981, EUR J PEDIATR, V137, P155
  • [8] VALUE AND LIMITS OF PHARMACOLOGICAL AND PHYSIOLOGICAL TESTS TO DIAGNOSE GROWTH-HORMONE (GH) DEFICIENCY AND PREDICT THERAPY RESPONSE - FIRST AND 2ND RETESTING DURING REPLACEMENT THERAPY OF PATIENTS DEFINED AS GH DEFICIENT
    CACCIARI, E
    TASSONI, P
    CICOGNANI, A
    PIRAZZOLI, P
    SALARDI, S
    BALSAMO, A
    CASSIO, A
    ZUCCHINI, S
    COLLI, C
    TASSINARI, D
    TANI, G
    GUALANDI, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) : 1663 - 1669
  • [9] Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: A population register-based study
    Carel, JC
    Tresca, JP
    Letrait, M
    Chaussain, JL
    Lebouc, Y
    Job, JC
    Coste, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) : 2117 - 2121
  • [10] Long term results of growth hormone treatment in France in children of short stature: population, register based study
    Coste, J
    Letrait, M
    Carel, JC
    Tresca, JP
    Chatelain, P
    Rochiccioli, P
    Louis, J
    Chaussain, JL
    Job, JC
    [J]. BRITISH MEDICAL JOURNAL, 1997, 315 (7110) : 708 - 713